表紙
市場調査レポート

組織診断の世界市場:2016〜2020年

Global Tissue Diagnostics Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 317834
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
組織診断の世界市場:2016〜2020年 Global Tissue Diagnostics Market 2016-2020
出版日: 2016年02月24日 ページ情報: 英文 72 Pages
概要

組織診断は、特定の組織を抽出し解析することで、疾患の診断を行なうとともに生物学的要因を解析するというものです。臨床研究、臨床診断、細胞生物学において広くもちいられています。世界の組織診断市場は、2016〜2020年にかけCAGR11.59%で拡大すると予測されています。

当レポートでは、世界の組織診断市場の現状と今後の成長見通し、技術別、製品別、疾患別、および地域別動向とともに、市場の動向と課題、主要ベンダーなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 世界の癌統計

第6章 償還と補償:概要

  • 現在のシナリオ:診断検査の妥当性評価
  • 米国における償還
  • EUにおける償還
  • 償還政策の課題

第7章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第8章 技術別市場セグメンテーション

  • 最新染色別
  • デジタル病理学別
  • 分析前および定期染色別

第9章 製品別市場セグメンテーション

  • 消耗品
  • 機器

第10章 疾患別市場セグメンテーション

  • 乳癌
  • 肺癌
  • 大腸癌
  • リンパ腫
  • 子宮頸癌
  • 前立腺癌
  • その他

第11章 エンドユーザー別市場セグメンテーション

  • 病院
  • CRO
  • 学術・研究機関

第12章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第13章 市場促進因子

第14章 促進因子の影響

第15章 市場の課題

第16章 促進因子および課題の影響

第17章 市場動向

第18章 ベンダー環境

  • 競合シナリオ
  • 市場シェア分析

第19章 付録

第20章 Technavioについて

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR8799

About Tissue Diagnostics

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.

Technavio's analysts forecast the global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:

  • Advanced staining
  • Preanalytical and routine staining
  • Digital pathology

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Diagnostics
  • Agilent Technologies (a parent company of Dako)
  • Danaher (a parent company of Leica Biosystems)
  • Roche Diagnostics

Other Prominent Vendors

  • 20/20 GeneSystems
  • Abcam
  • AdnaGen
  • Advanced Cell Diagnostics
  • Affymetrix
  • Agendia
  • AutoGenomics
  • AVIVA BioSciences
  • Biocare Medical
  • Biocartis
  • Cancer Genetics
  • ELITechGroup
  • Enzo Biochem
  • Epic Sciences
  • Fluidigm
  • HORIBA Medical
  • Janssen Diagnostics
  • Olympus Diagnostics Systems Group
  • Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
  • Oxford Gene Technology
  • PANAGENE
  • Protea Biosciences Group
  • Sakura Finetek

Market driver

  • Implementation by new customers
  • For a full, detailed list, view our report

Market challenge

  • Insurance coverage and reimbursement issues
  • For a full, detailed list, view our report

Market trend

  • Ready-to-use reagents
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Global cancer statistics

PART 06: Reimbursement and coverage: An overview

  • Current scenario: Validating diagnostic tests
  • Reimbursement structure in US
  • Reimbursement structure in EU
  • Prevailing issues of reimbursement policies

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by technology

  • Global tissue diagnostics market by advanced staining
  • Global tissue diagnostics market by digital pathology
  • Global tissue diagnostics market by preanalytical and routine staining

PART 09: Market segmentation by product

  • Global tissue diagnostics market segmentation by consumables
  • Global tissue diagnostics market segmentation by instruments

PART 10: Market segmentation by disease

  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Lymphoma
  • Cervical cancer
  • Prostate cancer
  • Other diseases

PART 11: Market segmentation by end-user

  • Hospitals
  • CROs
  • Academia and research institutes

PART 12: Geographical segmentation

  • Tissue diagnostics market in Americas
  • Tissue diagnostics market in EMEA
  • Tissue diagnostics market in APAC

PART 13: Market drivers

  • Prevalence of chronic diseases
  • Implementation by new consumers
  • Use of biomarkers for disease diagnosis
  • Demand for personalized medicine

PART 14: Impact of drivers

PART 15: Market challenges

  • Insurance coverage and reimbursement issues
  • Limitations of closed systems
  • High initial investment and maintenance costs

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Ready-to-use reagents
  • Focus on system automation
  • Increase in M&A

PART 18: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Prevalent cancer types worldwide 2012
  • Exhibit 03: Countries with highest cancer rate 2012
  • Exhibit 04: Cancer statistics by gender 2012
  • Exhibit 05: Reimbursement perspectives of healthcare entities
  • Exhibit 06: Global tissue diagnostics market 2015-2020 ($ billions)
  • Exhibit 07: Five forces analysis
  • Exhibit 08: Global tissue diagnostics market segmentation by technology
  • Exhibit 09: Global tissue diagnostics market segmentation by technology 2015
  • Exhibit 10: Global tissue diagnostics market segmentation by technology 2020
  • Exhibit 11: Global tissue diagnostics market segmentation by technology 2015-2020
  • Exhibit 12: Global tissue diagnostics market segmentation by advanced staining 2015
  • Exhibit 13: Global tissue diagnostics market segmentation by advanced staining 2020
  • Exhibit 14: Global tissue diagnostics market segmentation by advanced staining 2015-2020
  • Exhibit 15: Global tissue diagnostics market by IHC 2015-2020 ($ billions)
  • Exhibit 16: Global tissue diagnostics market by ISH 2015-2020 ($ millions)
  • Exhibit 17: Types of ISH
  • Exhibit 18: Comparative analysis of CISH, FISH, and IHC
  • Exhibit 19: Global tissue diagnostics market by advanced staining 2015-2020 ($ billions)
  • Exhibit 20: Geographical segmentation of global tissue diagnostics market by advanced staining 2015
  • Exhibit 21: Global tissue diagnostics market by digital pathology 2015-2020 ($ billions)
  • Exhibit 22: Geographical segmentation of global tissue diagnostics market by digital pathology 2015
  • Exhibit 23: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015
  • Exhibit 24: Global tissue diagnostics market segmentation by preanalytical and routine staining 2020
  • Exhibit 25: Global tissue diagnostics market segmentation by preanalytical and routine staining 2015-2020
  • Exhibit 26: Global tissue diagnostics market by preanalytical staining 2015-2020 ($ millions)
  • Exhibit 27: Global tissue diagnostics market by H&E staining 2015-2020 ($ millions)
  • Exhibit 28: Common special stains used for histological studies
  • Exhibit 29: Global tissue diagnostics market by special staining 2015-2020 ($ millions)
  • Exhibit 30: Global tissue diagnostics market by preanalytical and routine staining 2015-2020 ($ billions)
  • Exhibit 31: Geographical segmentation of global tissue diagnostics market by preanalytical and routine staining 2015
  • Exhibit 32: Global tissue diagnostics market segmentation by product
  • Exhibit 33: Global tissue diagnostics market segmentation by product 2015
  • Exhibit 34: Global tissue diagnostics market segmentation by product 2020
  • Exhibit 35: Global tissue diagnostics market segmentation by product 2015-2020
  • Exhibit 36: Global tissue diagnostics market by consumables 2015-2020 ($ billions)
  • Exhibit 37: Global tissue diagnostics market by instruments 2015-2020 ($ billions)
  • Exhibit 38: Global tissue diagnostics market segmentation by disease
  • Exhibit 39: Global tissue diagnostics market segmentation by disease type 2015
  • Exhibit 40: Global tissue diagnostics market segmentation by end-user
  • Exhibit 41: Global tissue diagnostics market segmentation by end-user 2015
  • Exhibit 42: Global tissue diagnostics market segmentation by geography 2015
  • Exhibit 43: Global tissue diagnostics market segmentation by geography 2020
  • Exhibit 44: Global tissue diagnostics market segmentation by geography 2015-2020
  • Exhibit 45: Tissue diagnostics market in Americas 2015-2020 ($ billions)
  • Exhibit 46: Segmentation of tissue diagnostics market in Americas by technology 2015
  • Exhibit 47: Tissue diagnostics market in EMEA 2015-2020 ($ billions)
  • Exhibit 48: Segmentation of tissue diagnostics market in EMEA by technology 2015
  • Exhibit 49: Tissue diagnostics market in APAC 2015-2020 ($ millions)
  • Exhibit 50: Segmentation of tissue diagnostics market in APAC by technology 2015
  • Exhibit 51: Impact of drivers
  • Exhibit 52: Impact of drivers and challenges
  • Exhibit 53: Ranking of top vendors 2015
  • Exhibit 54: Roche Diagnostics: Key takeaways
  • Exhibit 55: Agilent Technologies: Key takeaways
  • Exhibit 56: Danaher: Key takeaways
  • Exhibit 57: Abbott Diagnostics: Key takeaways
Back to Top